Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension

By  

Current Vascular Pharmacology, Vol. 10, Iss. 3, 2012-05 ,pp. : 289-299

Bentham Science Publishers

Access to resources Recommend Favorite

Design of a Genetically Modified Soybean Protein Preventing Hypertension Based on an Anti-Hypertensive Peptide Derived from Ovalbumin

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 2, 2003-06 ,pp. : 197-202

Bentham Science Publishers

Access to resources Recommend Favorite

Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. - A preliminary study

By Cedro K.   Radomski A.   Radomski M.W.   Ruzyllo W.   Herbaczynska-Cedro K.  

International Journal of Cardiology, Vol. 92, Iss. 2, 2003-12 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite

Acid Control Cannot Be Improved with a Modified-Release Formulation of a Proton Pump Inhibitor Compared with Twice-Daily Dosing of the Conventional Formulation

By Röhss Kerstin   Wilder-Smith Clive   Bokelund-Singh Sara   Sagar Mohamed   Nagy Péter  

Digestive Diseases and Sciences, Vol. 55, Iss. 12, 2010-12 ,pp. : 3423-3429

Springer Publishing Company

Access to resources Recommend Favorite

Modified Release Biodegradable Polymeric Microspheres of Stavudine: Cell Viability, Cellular Uptake, Hemolysis Studies and In Vivo Pharmacokinetics

By  

Current HIV Research, Vol. 13, Iss. 6, 2015-01 ,pp. : 503-516

Bentham Science Publishers

Access to resources Recommend Favorite